6 results
10-K
2013 FY
RVNC
Revance Therapeutics Inc
28 Mar 14
Annual report
12:00am
these consumers were representative of the 27 million women in the United States who fit this demographic profile. The participants were recruited
424B4
RVNC
Revance Therapeutics Inc
6 Feb 14
Prospectus supplement with pricing info
12:00am
would consider aesthetic treatments. We believe these consumers were representative of the
27 million women in the United States who fit this demographic
S-1
9agnll3evgx65n1m0n3
31 Dec 13
IPO registration
12:00am
- Prev
- 1
- Next